Obstetric and Gynecologic Imaging

What Is the Best Follow-Up Imaging for Established Fetal Growth Restriction?

·
What Is the Best Follow-Up Imaging for Established Fetal Growth Restriction?

A 32-year-old G2P1 at 34 weeks gestation returns for a follow-up appointment. Two weeks prior, an ultrasound confirmed fetal growth restriction (FGR), with an estimated fetal weight below the 5th percentile. The patient is anxious, and you need to determine the optimal imaging strategy to monitor fetal well-being and guide the timing of delivery. This is not an initial diagnosis but a crucial surveillance decision point where the fetus is at known risk for adverse outcomes. For this specific scenario—follow-up evaluation of established fetal growth restriction—the American College of Radiology (ACR) rates several ultrasound-based studies as key components of assessment, with US duplex Doppler of the ductus venosus being a critical evaluation that is Usually Appropriate.

Who Fits This Clinical Scenario?

This guidance applies specifically to pregnant patients with a previously diagnosed and established case of fetal growth restriction. The key inclusion criterion is a confirmed diagnosis, typically defined by an estimated fetal weight (EFW) or abdominal circumference (AC) less than the 10th percentile for gestational age, often accompanied by other supporting findings. The clinical question is not “Does this fetus have FGR?” but rather “How is this growth-restricted fetus tolerating the intrauterine environment, and is delivery indicated?”

This workflow is distinct from the initial evaluation of a patient who is merely at risk for FGR. This article does not apply to:

  • Low-risk patients for FGR: A patient with no risk factors who presents with a fundal height that measures slightly small for dates would undergo an initial evaluation, which is a different clinical scenario.
  • High-risk patients for FGR: A patient with risk factors like chronic hypertension or a prior history of FGR, but without a current confirmed diagnosis, would also follow an initial evaluation pathway, not this surveillance protocol.

The focus here is exclusively on serial monitoring after the diagnosis has been made to assess for progression of placental dysfunction and signs of fetal decompensation.

What Diagnoses Are You Working Up in This Scenario?

In the follow-up of established FGR, imaging is not used to find a new diagnosis but to stage the severity of the underlying pathophysiology and detect impending fetal compromise. The primary concern is progressive uteroplacental insufficiency.

Worsening Placental Dysfunction: This is the most common cause of FGR and the primary target of surveillance. The placenta is failing to provide adequate oxygen and nutrients. Doppler ultrasonography directly assesses the hemodynamic consequences of this failure by measuring blood flow resistance in key fetal vessels. Worsening parameters indicate the placenta’s function is deteriorating.

Fetal Hypoxemia and “Brain Sparing”: As placental insufficiency worsens, the fetus adapts to chronic hypoxia by shunting oxygenated blood preferentially to the brain, heart, and adrenal glands, at the expense of other organs. This phenomenon, known as the “brain-sparing effect,” can be detected by comparing Doppler indices in the middle cerebral artery (MCA) and umbilical artery (UA). It is a sign of significant fetal stress.

Impending Fetal Decompensation: This is the most critical condition being monitored. As fetal compromise becomes severe, central venous circulation is affected. Abnormal flow in the ductus venosus (DV) is a late and ominous sign, reflecting cardiac dysfunction and increased risk for acidemia and stillbirth. Identifying this stage is a primary goal of follow-up imaging, as it often necessitates immediate delivery.

Oligohydramnios: Reduced amniotic fluid volume is a common co-finding in FGR, resulting from decreased fetal urine production due to blood flow redistribution away from the kidneys. It is an independent marker of chronic placental insufficiency and is associated with an increased risk of adverse perinatal outcomes.

Why Is a Suite of Doppler Ultrasounds the Recommended Approach?

For the follow-up of established FGR, a comprehensive ultrasound assessment including biometry, amniotic fluid assessment, and multi-vessel Doppler interrogation is the standard of care. According to the ACR, US duplex Doppler of the ductus venosus, fetal middle cerebral artery, and fetal umbilical artery are all rated Usually Appropriate. A biophysical profile (BPP) and standard transabdominal ultrasound for fetal biometry are also Usually Appropriate and performed concurrently.

The rationale for this multi-pronged approach is that different vessels reflect different stages of fetal compromise:

  • Umbilical Artery (UA) Doppler: This is the foundational assessment. Increased resistance (high Systolic/Diastolic ratio or Pulsatility Index) in the UA reflects high downstream resistance in the placental vascular bed. The progressive absence, and eventual reversal, of end-diastolic flow (AREDV) is a specific marker of severe placental disease and is associated with a significant increase in perinatal morbidity and mortality.
  • Middle Cerebral Artery (MCA) Doppler: This assesses the fetal response to hypoxia. A low Pulsatility Index in the MCA indicates vasodilation, the “brain-sparing” effect. The cerebroplacental ratio (CPR), which compares the MCA and UA Pulsatility Indices, is a more sensitive predictor of adverse outcomes than either vessel alone.
  • Ductus Venosus (DV) Doppler: This is a view into the fetal central venous system and cardiac function. Abnormal waveforms (increased Pulsatility Index, absent or reversed ‘a’-wave) are late findings that correlate strongly with fetal acidemia and impending decompensation. An abnormal DV Doppler is often a trigger for delivery, even in a preterm fetus.

An alternative study, US duplex Doppler of the maternal uterine artery, is rated May be appropriate in this context. While abnormal uterine artery Dopplers are highly predictive of FGR when assessed in the second trimester, their utility for serial surveillance in the third trimester after FGR is already established is less clear. The primary focus in follow-up is on the fetal response, not the maternal vessels.

All recommended ultrasound modalities carry an adult and pediatric radiation-related risk level of O (0 mSv), making them safe for repeated use throughout pregnancy.

What’s Next After Doppler Ultrasound? Downstream Workflow

The results of the follow-up ultrasound and Doppler studies directly guide clinical management, primarily the frequency of subsequent surveillance and the timing of delivery. The workflow is stratified by risk.

  • If studies are reassuring: If the EFW remains on its curve (even if small), amniotic fluid is normal, and all Doppler values (UA, MCA, DV) are within normal limits, surveillance can continue. The interval for repeat assessment typically ranges from 1 to 2 weeks, depending on the gestational age and severity of growth restriction.
  • If studies show early signs of compromise: Findings like an elevated UA Pulsatility Index or evidence of brain sparing (low MCA PI or abnormal CPR) indicate significant fetal stress. This prompts an increase in surveillance frequency, often to twice-weekly testing with BPPs and weekly Dopplers. Administration of antenatal corticosteroids to promote fetal lung maturity should be strongly considered if the fetus is preterm.
  • If studies show late/severe signs of compromise: The presence of absent or reversed end-diastolic flow in the umbilical artery, or abnormal ductus venosus waveforms, are ominous findings. These results warrant immediate consultation with a maternal-fetal medicine specialist, hospital admission for continuous monitoring, and planning for imminent delivery, regardless of gestational age. The risk of intrauterine demise often outweighs the risks of prematurity at this stage.

An indeterminate or technically limited study should prompt a repeat assessment within 24-48 hours or an escalation to a center with more expertise in fetal Doppler assessment.

Pitfalls to Avoid (and When to Get Help)

Navigating the follow-up of FGR requires careful interpretation and timely action. Common pitfalls include:

  • Over-reliance on EFW alone: A stable EFW percentile does not guarantee fetal well-being. Hemodynamic changes detected by Doppler often precede changes in growth or a drop in the biophysical profile score.
  • Incorrect Doppler technique: Doppler indices are highly dependent on obtaining the correct angle of insonation and sampling from the correct vessel location. Inaccurate measurements can lead to false reassurance or unnecessary intervention.
  • Extending surveillance intervals inappropriately: In cases with abnormal UA Dopplers, extending the follow-up period beyond one week can risk missing a rapid deterioration in fetal status.
  • Ignoring the complete clinical picture: Doppler findings should always be integrated with gestational age, maternal condition (e.g., worsening preeclampsia), and BPP results to make the final decision about delivery.

If you encounter critical findings such as reversed end-diastolic flow in the umbilical artery, an abnormal ductus venosus Doppler, or a low biophysical profile score (≤4/10), this is a clear signal to escalate. Immediate consultation with a maternal-fetal medicine specialist is critical for co-management and delivery planning.

Related ACR Topics and Tools

For a comprehensive overview of all clinical scenarios related to fetal growth disturbances, from initial risk assessment to follow-up, please see the parent topic article. For additional resources on applying appropriateness criteria and understanding imaging protocols, the following tools are available.

Frequently Asked Questions

How often should follow-up ultrasound be performed for established Fetal Growth Restriction?

The frequency depends on the severity of findings. For FGR with normal Doppler studies, surveillance every 1-2 weeks may be sufficient. If umbilical artery Dopplers are abnormal, frequency increases to 1-2 times per week. With critical findings like reversed end-diastolic flow, daily assessment or immediate delivery is often necessary.

What is the key difference between umbilical artery and ductus venosus Doppler in FGR?

Umbilical artery (UA) Doppler primarily reflects the health and resistance of the placenta. Abnormal UA flow is an earlier sign of placental dysfunction. Ductus venosus (DV) Doppler reflects fetal cardiac function and central venous pressures. Abnormal DV flow is a late and more ominous sign, indicating the fetus is failing to cope and is at high risk of acidemia and injury.

If the biophysical profile (BPP) is normal (e.g., 8/8), are Doppler studies still necessary?

Yes. The BPP is an assessment of acute fetal well-being, while Dopplers assess the underlying chronic pathophysiology of placental insufficiency. Abnormal Doppler findings can predate a drop in the BPP score by days or even weeks. In established FGR, both are complementary and necessary components of surveillance.

What is ‘brain sparing’ and what does it signify?

Brain sparing is a fetal adaptive mechanism to chronic hypoxia. The fetus shunts oxygenated blood to the brain by dilating the middle cerebral artery (MCA). This is detected as a low Pulsatility Index (PI) on MCA Doppler. While it is a compensatory mechanism, its presence indicates significant underlying fetal stress and warrants closer surveillance.

When is maternal uterine artery Doppler useful in FGR management?

Maternal uterine artery Doppler is most useful as a screening tool in the second trimester (around 20-24 weeks) to predict the risk of developing FGR or preeclampsia later in pregnancy. In the third trimester, once FGR is already established, its utility for ongoing management is limited. The focus shifts to direct fetal assessment with umbilical, MCA, and ductus venosus Dopplers.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026